Cargando…

Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity

[Image: see text] Washing is a key step in pharmaceutical isolation to remove the unwanted crystallization solvent (mother liquor) from the active pharmaceutical ingredient (API) filter cake. This study looks at strategies for optimal wash solvent selection, which minimizes the dissolution of API pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Muhid, Sanxaridou, Georgia, Ottoboni, Sara, Lue, Leo, Price, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057229/
https://www.ncbi.nlm.nih.gov/pubmed/33897252
http://dx.doi.org/10.1021/acs.oprd.1c00005
_version_ 1783680798929453056
author Shahid, Muhid
Sanxaridou, Georgia
Ottoboni, Sara
Lue, Leo
Price, Chris
author_facet Shahid, Muhid
Sanxaridou, Georgia
Ottoboni, Sara
Lue, Leo
Price, Chris
author_sort Shahid, Muhid
collection PubMed
description [Image: see text] Washing is a key step in pharmaceutical isolation to remove the unwanted crystallization solvent (mother liquor) from the active pharmaceutical ingredient (API) filter cake. This study looks at strategies for optimal wash solvent selection, which minimizes the dissolution of API product crystals while preventing the precipitation of product or impurities. Selection of wash solvents to avoid both these phenomena can be challenging but is essential to maintain the yield, purity, and particle characteristics throughout the isolation process. An anti-solvent screening methodology has been developed to quantitatively evaluate the propensity for precipitation of APIs and their impurities of synthesis during washing. This is illustrated using paracetamol (PCM) and two typical impurities of synthesis during the washing process. The solubility of PCM in different binary wash solutions was measured to provide a basis for wash solvent selection. A map of wash solution composition boundaries for precipitation for the systems investigated was developed to depict where anti-solvent phenomena will take place. For some crystallization and wash solvent combinations investigated, as much as 90% of the dissolved PCM and over 10% of impurities present in the PCM saturated mother liquor were found to precipitate out. Such levels of uncontrolled crystallization during washing in a pharmaceutical isolation process can have a drastic effect on the final product purity. Precipitation of both the product and impurities from the mother liquor can be avoided by using a solvent in which the API has a solubility similar to that in the mother liquor; for example, the use of acetonitrile as a wash solvent does not result in precipitation of either the PCM API or its impurities. However, the high solubility of PCM in acetonitrile would result in noticeable dissolution of API during washing and would lead to agglomeration during the subsequent drying step. Contrarily, the use of n-heptane as a wash solvent for a PCM crystal slurry resulted in the highest amount of precipitation among the solvent pairs evaluated. This can be mitigated by designing a multi-stage washing strategy where wash solutions of differing wash solvent concentrations are used to minimize step changes in solubility when the mother liquor and the wash solvent come into contact.
format Online
Article
Text
id pubmed-8057229
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-80572292021-04-21 Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity Shahid, Muhid Sanxaridou, Georgia Ottoboni, Sara Lue, Leo Price, Chris Org Process Res Dev [Image: see text] Washing is a key step in pharmaceutical isolation to remove the unwanted crystallization solvent (mother liquor) from the active pharmaceutical ingredient (API) filter cake. This study looks at strategies for optimal wash solvent selection, which minimizes the dissolution of API product crystals while preventing the precipitation of product or impurities. Selection of wash solvents to avoid both these phenomena can be challenging but is essential to maintain the yield, purity, and particle characteristics throughout the isolation process. An anti-solvent screening methodology has been developed to quantitatively evaluate the propensity for precipitation of APIs and their impurities of synthesis during washing. This is illustrated using paracetamol (PCM) and two typical impurities of synthesis during the washing process. The solubility of PCM in different binary wash solutions was measured to provide a basis for wash solvent selection. A map of wash solution composition boundaries for precipitation for the systems investigated was developed to depict where anti-solvent phenomena will take place. For some crystallization and wash solvent combinations investigated, as much as 90% of the dissolved PCM and over 10% of impurities present in the PCM saturated mother liquor were found to precipitate out. Such levels of uncontrolled crystallization during washing in a pharmaceutical isolation process can have a drastic effect on the final product purity. Precipitation of both the product and impurities from the mother liquor can be avoided by using a solvent in which the API has a solubility similar to that in the mother liquor; for example, the use of acetonitrile as a wash solvent does not result in precipitation of either the PCM API or its impurities. However, the high solubility of PCM in acetonitrile would result in noticeable dissolution of API during washing and would lead to agglomeration during the subsequent drying step. Contrarily, the use of n-heptane as a wash solvent for a PCM crystal slurry resulted in the highest amount of precipitation among the solvent pairs evaluated. This can be mitigated by designing a multi-stage washing strategy where wash solutions of differing wash solvent concentrations are used to minimize step changes in solubility when the mother liquor and the wash solvent come into contact. American Chemical Society 2021-03-12 2021-04-16 /pmc/articles/PMC8057229/ /pubmed/33897252 http://dx.doi.org/10.1021/acs.oprd.1c00005 Text en © 2021 The Authors. Published by American Chemical Society Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Shahid, Muhid
Sanxaridou, Georgia
Ottoboni, Sara
Lue, Leo
Price, Chris
Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title_full Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title_fullStr Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title_full_unstemmed Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title_short Exploring the Role of Anti-solvent Effects during Washing on Active Pharmaceutical Ingredient Purity
title_sort exploring the role of anti-solvent effects during washing on active pharmaceutical ingredient purity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057229/
https://www.ncbi.nlm.nih.gov/pubmed/33897252
http://dx.doi.org/10.1021/acs.oprd.1c00005
work_keys_str_mv AT shahidmuhid exploringtheroleofantisolventeffectsduringwashingonactivepharmaceuticalingredientpurity
AT sanxaridougeorgia exploringtheroleofantisolventeffectsduringwashingonactivepharmaceuticalingredientpurity
AT ottobonisara exploringtheroleofantisolventeffectsduringwashingonactivepharmaceuticalingredientpurity
AT lueleo exploringtheroleofantisolventeffectsduringwashingonactivepharmaceuticalingredientpurity
AT pricechris exploringtheroleofantisolventeffectsduringwashingonactivepharmaceuticalingredientpurity